Dr. Scott Gottlieb on Novo Nordisk vs. Hims & Hers: We have a drug approval process for a reason

Let's talk all things public health this morning, including the fight between Novo Nordisk and hims and hers over GLP-1 drugs. Joining us right now is CNBC contributor Dr. . Scott Gotautle.He is the former commissioner of the FDA and he serves on the boards of both Aluminina, Fizer, and United Health. He's also on the CNBC cures advisory board. And Scott, thank you for coming in today.>> Thanks a lot. >> Uh, break this down for us. hims and hers big splashy announcement last week that they were going to be ...